MGF (Mechano Growth Factor) vs PEG-MGF

MGF (Mechano Growth Factor)

A splice variant of IGF-1 that the body produces locally inside exercising muscle. Used as a post-workout intramuscular shot to amplify the local growth signal in trained tissue only.

Best for

Best for targeted post-workout injections into the specific muscle you want to repair.

PEG-MGF

Pegylated MGF — the same satellite-cell-activating peptide as regular MGF, but with a polyethylene glycol chain that stretches the half-life from minutes to days. Trades the locality story for twice-weekly convenience.

Best for

Best when you want a longer systemic half-life instead of a purely local effect.

MGF (Mechano Growth Factor)

The endogenous role of the IGF-1Ec splice variant in satellite-cell activation is well established in muscle biology — animal models from the early 2000s mapped the mechanism in detail. Injectable MGF for hypertrophy in healthy adults is supported by small case series and community use, not by completed RCTs. The half-life problem (minutes in circulation) makes traditional clinical trial design awkward, which is part of why the human literature is so thin.

PEG-MGF

The pegylation chemistry is well established from drug-development work on PEG-Filgrastim, PEG-Interferon, and other approved pegylated biologics. The specific PEG-MGF molecule has not been subjected to dedicated human RCTs for hypertrophy in healthy adults. The endogenous biology of the parent MGF molecule is preclinically well characterised; the leap from that to PEG-MGF as a hypertrophy tool is plausible but unproven in formal trials.